| |
Schizophrenia Research provides rapid publication of new international research that contributes to
the understanding of schizophrenia and related disorders. The journal brings together previously separated biological, clinical and psychological
research on this disorder, and stimulates the synthesis of clinical and research data into cohesive hypthesis.
Types of papers:
(1) Full-length papers: 2000-3000 words (excluding tables, figures and references).
(2) Short communications: 1000-1500 words (excluding
tables, figures and references).
(3) Letters to the Editors: 600-800 words, 10 references, 1 figure or table.
(4) Special solicited research
and/or reviews.
(5) Invited comments or hypotheses.
(6) Editorials.
(7) Schizophrenia meeting reviews; solicited and/or submitted.
(8)
Book reviews.
Submission Checklist:
It is hoped that this list will be useful during the final checking of an article
prior to sending it to the journal's editor for review. Please consult this Guide for Authors for further details of any item.
Ensure
that the following items are present:
•One author designated as corresponding author
•E-mail address
•Full
postal address
•Telephone and fax numbers
•All necessary files have been uploaded
•Keywords
•All
figure captions
•All tables (including title, description, footnotes)
Further considerations
•Manuscript
has been "spell checked"
•References are in the correct format for this journal
•All references mentioned in the Reference
list are cited in the text, and vice versa
•Permission has been obtained for use of copyrighted material from other sources
(including the Web)
•Colour figures are clearly marked as being intended for colour reproduction or to be reproduced in black-and-white
General
Submission of an article implies that the work described has not been published previously (except in the form
of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that
its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and
that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, without the written consent
of the Publisher.
Upon acceptance of an article, you will be asked to transfer copyright (for more information on copyright see
 http://authors.elsevier.com/journal/schres. This transfer will ensure the widest possible dissemination of information.
If excerpts from other copyrighted works are included in the submission, the author(s) must obtain written permission from the copyright
owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: contact Elsevier's Rights
Department, Philadelphia, PA, USA: phone (+1) 215 238 7869, fax (+1) 215 238 2239, e-mail healthpermissions@elsevier.com.
Requests for materials from other Elsevier publications may also be completed on-line via the Elsevier homepage http://www.elsevier.com/locate/permissions
Submission of manuscripts
Schizophrenia Research proceeds totally online via the Elsevier Editorial System. In
case you do not have an Internet connection, please contact the appropriate Editorial Office for alternative instructions. By accessing
the online submission at http://www.ees.elsevier.com/schres you will be guided stepwise through the creation and uploading
of the various files. When submitting a manuscript online, authors need to provide an electronic version of their manuscript and any
accompanying figures and tables and are requested to direct the manuscripts to the most appropriate Editor.
Once the uploading is
done, the system automatically generates an electronic (PDF) proof, which is then used for reviewing. All correspondence, including the
Editor's decision and request for revisions, will be processed through the system and will reach the corresponding author by e-mail.
Once a manuscript has successfully been submitted via the online submission system authors may track the status of their manuscript
using the online submission system (details will be provided by e-mail). If your manuscript is accepted by the journal, subsequent tracking
facilities are available on Elsevier's Author Gateway, using the unique reference number provided by Elsevier and corresponding author
name (details will be provided by e-mail).
Authors may send queries concerning the submission process or journal procedures to the
Editorial Offices:
For the Americas:
Editor-in-Chief Henry A. Nasrallah, M.D., Department of Psychiatry, University
of Cincinnati Medical Center, Cincinnati, OH USA Tel: +1 513 558 4615, Fax: +1 513 558 4616, E-mail: Henry.nasrallah@uc.edu
Managing Editor Amelia T. Nasrallah, Amelia.nasrallah@uc.edu
For outside the Americas:
Editor-in-Chief Lynn E. DeLisi, M.D. Department of Psychiatry, New York University, The Nathan S. Kline Institute for Psychiatry Research, Orangeburg,
NY USA, Tel: +1 212 263 3406, E-mail: Delisi76@aol.com
Managing Editor Gul A. Jabbar, Gul_Jabbar@hms.harvard.edu
For further details on how to submit online, please refer to the online EES Tutorial for authors. Alternatively please contact the
Author Support Team at esubmissionsupport@elsevier.com or the Reviewers Support Team at reviewersupport@elsevier.com
Elsevier also provides 24/7 Telephone Support for:
The Americas: +1 888 834 7287
Asia & Pacific: +81 3 5561 5032
Europe & ROW: +353 61 709 190
Presentation of manuscript
Please write your text
in good English (American or British usage is accepted, but not a mixture of these). Italics are not to be used for expressions of Latin
origin, for example, in vivo, et al., per se. Use decimal points (not commas); use a space for thousands (10 000 and above).
Provide
the following data on the title page (in the order given).
Title. Concise and informative. The title should indicate the
main point of the manuscript. Note that titles are often used in information-retrieval systems. Avoid abbreviations and formulae where
possible.
Author names and affiliations. Where the family name may be ambiguous (e.g., a double name), please indicate this
clearly. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with
a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Provide the full postal
address of each affiliation, including the country name, and, if available, the e-mail address of each author.
Corresponding
author. Clearly indicate who is willing to handle correspondence at all stages of refereeing and publication, also post-publication.
Ensure that telephone and fax numbers (with country and area code) are provided in addition to the e-mail address and the complete postal
address.
Present/permanent address. If an author has moved since the work described in the article was done, or was visiting
at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to that author's name. The address at which
the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
Abstract. A concise and factual abstract is required (maximum length 250 words for full-length papers or 100 words for short
communications). The abstract should state briefly the purpose of the research, the principal results and major conclusions. An abstract
is often presented separate from the article, so it must be able to stand alone. References should therefore be avoided, but if essential,
they must be cited in full, without reference to the reference list. Non-standard or uncommon abbreviations should be avoided, but if
essential they must be defined at their first mention in the abstract itself.
Keywords. Immediately after the abstract,
provide a maximum of six keywords, using American spelling and avoiding general and plural terms and multiple concepts (avoid, for example,
'and', 'of'). Be sparing with abbreviations: only abbreviations firmly established in the field may be eligible. These keywords will
be used for indexing purposes.
Abbreviations. Define abbreviations that are not standard in this field at their first occurrence
in the article: in the abstract but also in the main text after it. Ensure consistency of abbreviations throughout the article.
Arrangement
of the article
Subdivision of the article. Divide your article into clearly defined and numbered sections. Subsections
should be numbered 1.1 (then 1.1.1, 1.1.2, ?), 1.2, etc. (the abstract is not included in section numbering). Use this numbering also
for internal cross-referencing: do not just refer to 'the text'. Any subsection may be given a brief heading. Each heading should appear
on its own separate line.
Introduction. State the objectives of the work and provide an adequate background, avoiding a
detailed literature survey or a summary of the results.
Experimental/Materials and methods. Provide sufficient detail to
allow the work to be reproduced. Methods already published should be indicated by a reference: only relevant modifications should be
described. Statistical tests used for evaluation of data should be briefly explained. In case of experimental studies, animals used should
be described, including information on breed, breeder, sex, age, weight and the maintenance conditions. Special chemicals and their sources
should be grouped under a separate sub-heading. For drugs generic names should be used; trade names may be given in brackets where the
drug is first mentioned. In case of a new drug, a chemical description (formula) should be given. The form of a drug used should also
be indicated.
Results. In this section the findings should be described clearly, concisely, and in logical order without
extended discussions of their significance. Only in case of short communications, the results and discussion sections may be combined.
Results should usually be presented in graphic or tabular form, rather than discursively. There should be no duplication in text, tables and figures. Experimental conclusions should normally be based on adequate numbers of observations with statistical analysis of variance
and the significance of differences. The number of individual values represented by a mean should be indicated.
Discussion.
This section should present conclusions to be drawn from the results accompanied by an assessment of their significance in relation to
previous work. Speculative discussion is not discouraged, but the speculation should be based on the data presented and identified as
such. In general, the discussion should be as concise as possible.
Author Disclosure - NEW!!
Role of Funding
Source. Authors are kindly requested to briefly describe the role of the study sponsor(s), if any, in study design; in the collection,
analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. If the funding
source(s) had no such involvement, authors should so state.
eg, Funding for this study was provided by NIMH Grant XXXXXXX; the
NIMH had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in
the decision to submit the paper for publication.
Following the Role of the Funding Source text, authors are required
to declare their individual contribution to the manuscript under a subheading Contributors.
eg, Author X designed the
study and wrote the protocol. Author Y managed the literature searches and analyses. Authors X and Z undertook the statistical analysis,
and author W wrote the first draft of the manuscript. All authors contributed to and have approved the final manuscript.
The
third aspect of the Journal's new policy concerns the Conflict of Interest. ALL authors are requested to disclose any actual or
potential conflict of interest including any financial, personal or other relationships with other people or organizations within three
(3) years of beginning the work submitted that could inappropriately influence, or be perceived to influence, their work.
Examples
of potential conflicts of interest which should be disclosed include employment, consultancies, stock ownership (except for personal
investment purposes equal to the lesser of one percent (1%) or USD 5000), honoraria, paid expert testimony, patent applications, registrations,
and grants. If there are no conflicts of interest, authors should state that there are none.
eg, Author Y owns shares in pharma
company A. Author X and Z have consulted for pharma company B. All other authors declare that they have no conflicts of interest.
Finally, before the references, the Journal will publish Acknowledgements, in a separate section, and not as a footnote on
the title page.
eg, We thank Mr A, who kindly provided the data necessary for our analysis, and Miss B, who assisted with the
preparation and proof-reading of the manuscript.
NB. During the online submission process the author will be prompted
to upload these four mandatory author disclosures as separate items. They will be automatically incorporated in the PDF builder
of the online submission system. Please do not include in the main manuscripts.
References. See separate section, below.
Figure legends, tables, figures, schemes. Present these, in this order, at the end of the article. Figures and photographs
of good quality should also be submitted online as a separate file.
Tables. Number tables consecutively in accordance with
their appearance in the text. Place footnotes to tables below the table body and indicate them with superscript lowercase letters. Avoid
vertical rules. Be sparing in the use of tables and ensure that the data presented in tables do not duplicate results described elsewhere
in the article.
Nomenclature and units. Follow internationally accepted rules and conventions: use the international system
of units (SI). If other quantities are mentioned, give their equivalent in SI.
DNA sequences and GenBank Accession numbers.
Many Elsevier journals cite "gene accession numbers" in their running text and footnotes. Gene accession numbers refer to genes or DNA
sequences about which further information can be found in the databases at the National Center for Biotechnical Information (NCBI) at
the National Library of Medicine. Elsevier authors wishing to enable other scientists to use the accession numbers cited in their papers
via links to these sources, should type this information in the following manner:
For each and every accession number cited in
an article, authors should type the accession number
in bold
,
underlined text
. Letters in the accession
number should always be capitalised. (See Example below). This combination of letters and format will enable Elsevier's typesetters to
recognise the relevant texts as accession numbers and add the required link to GenBank's sequences.
Example: "GenBank accession
nos.
AI631510, AI631511, AI632198, and BF223228
), a B-cell tumor from a chronic lymphatic leukemia
(GenBank accession no.
BE675048
), and a T-cell lymphoma (GenBank accession no.
AA361117
)".
Authors are
encouraged to check accession numbers used very carefully. An error in a letter or number can result in a dead link. In the final
version of the
printed
article, the accession number text will not appear bold or underlined. In the final version
of the
electronic
copy, the accession number text will be linked to the appropriate source in the NCBI databases
enabling readers to go directly to that source from the article.
Preparation of supplementary data. Elsevier accepts electronic
supplementary material to support and enhance your scientific research. Supplementary files offer the author additional possibilities
to publish supporting applications, movies, animation sequences, high-resolution images, background datasets, sound clips and more. Supplementary
files supplied will be published online alongside the electronic version of your article in Elsevier web products, including ScienceDirect:
http://www.sciencedirect.com. In order to ensure that your submitted material is directly usable, please ensure that data
is provided in one of our recommended file formats. Authors should submit the material in electronic format together with the article
and supply a concise and descriptive caption for each file. For more detailed instructions please visit our Author Gateway at http://authors.elsevier.com.
Policy and ethics. The work described in your article must have been carried out in accordance with The Code of Ethics of
the World Medical Association (Declaration of Helsinki) for experiments involving humans; http://www.wma.net/e/policy/b3.htm
and with the internationally accepted principles in the care and use of experimental animals. This must be stated at an appropriate
point in the article.
References
Responsibility for the accuracy of bibliographic citations lies entirely with the authors.
Citations in the text:Please ensure that every reference cited in the text is also present in the reference list (and vice
versa). Any references cited in the abstract must be given in full. Unpublished results and personal communications should not be in
the reference list, but may be mentioned in the text. Citation of a reference as 'in press' implies that the item has been accepted for
publication and a copy of the title page of the relevant article must be submitted.
Citing and listing of web references.
As a minimum, the full URL should be given. Any further information, if known (author names, dates, reference to a source publication,
etc.), should also be given. Web references can be listed separately (e.g., after the reference list) under a different heading if desired,
or can be included in the reference list.
Text: All citations in the text should refer to:
1. Single author:
the author's name (without initials, unless there is ambiguity) and the year of publication;
2. Two authors: both authors'
names and the year of publication;
3. Three or more authors: first author's name followed by 'et al.' and the year of publication.
Citations may be made directly (or parenthetically). Groups of references should be listed first alphabetically, then chronologically.
Examples: "as demonstrated (Allan, 1996a, 1996b, 1999; Allan and Jones, 1995). Kramer et al. (2000) have recently shown
...."
List: References should be arranged first alphabetically and then further sorted chronologically if necessary. More
than one reference from the same author(s) in the same year must be identified by the letters "a", "b", "c", etc., placed after the year
of publication.
Examples:
Reference to a journal publication:
Van der Geer, J., Hanraads, J.A.J., Lupton,
R.A., 2000. The art of writing a scientific article. J. Sci. Commun. 163 (2) 51-59.
Reference to a book:
Strunk Jr.,
W., White, E.B., 1979. The Elements of Style, third ed. Macmillan, New York.
Reference to a chapter in an edited book:
Mettam, G.R., Adams, L.B., 1999. How to prepare an electronic version of your article, in: Jones, B.S., Smith , R.Z. (Eds.), Introduction
to the Electronic Age. E-Publishing Inc., New York, pp. 281-304.
Journal names should be abbreviated according to the List of serial
title word abbreviations: http://www.issn.org/lstwa.html
Preparation of electronic illustrations and services
General points
•Always supply high-quality printouts of your artwork, in case conversion of the electronic artwork
is problematic.
•Make sure you use uniform lettering and sizing of your original artwork.
•Save text in illustrations
as "graphics" or enclose the font.
•Only use the following fonts in your illustrations: Arial, Courier, Helvetica, Times, Symbol.
•Number the illustrations according to their sequence in the text.
•Use a logical naming convention for your artwork files,
and supply a separate listing of the files and the software used.
•Upload all illustrations as separate files.
•Provide
captions to illustrations separately.
•Produce images near to the desired size of the printed version. This journal offers electronic
submission services and graphic files can be uploaded via the online submission system.
A detailed guide on electronic artwork is
available on our website:
http://authors.elsevier.com/artwork/schres
You are urged to visit this site; some excerpts
from the detailed information are given here.
Formats
Regardless of the application used, when your electronic artwork
is finalised, please "save as" or convert the images to one of the following formats (Note the resolution requirements for line drawings,
halftones, and line/halftone combinations given below.):•EPS: Vector drawings. Embed the font or save the text as "graphics".
•TIFF: Colour or greyscale photographs (halftones): always use a minimum of 300 dpi.
•TIFF: Bitmapped line drawings: use
a minimum of 1000 dpi.
•TIFF: Combinations bitmapped line/half-tone (colour or greyscale): a minimum of 500 dpi is required.
•DOC, XLS or PPT: If your electronic artwork is created in any of these Microsoft Office applications please supply "as is".
Please do not:
•Supply embedded graphics in your wordprocessor (spreadsheet, presentation) document;
•Supply
files that are optimised for screen use (like GIF, BMP, PICT, WPG); the resolution is too low;
•Supply files that are too low
in resolution;
•Submit graphics that are disproportionately large for the content.
Captions
Ensure that each
illustration has a caption. Supply captions on a separate sheet, not attached to the figure. A caption should comprise a brief title
(not on the figure itself) and a description of the illustration. Keep text in the illustrations themselves to a minimum but explain
all symbols and abbreviations used.
Colourful e-Products
Figures that appear in black & white in print appear in
colour, online, in ScienceDirect at http://www.sciencedirect.com. There is no extra charge for authors who participate.
For colour reproduction in print, you will receive information regarding the costs from Elsevier after receipt of your accepted
article. Please indicate your preference for colour in print or on the Web only. Because of technical complications, which can arise
by converting colour figures to "grey scale" (for the printed version should you not opt for colour in print) please submit in addition
usable black and white versions of all the colour illustrations. For further information on the preparation of electronic artwork, please
see http://authors.elsevier.com/artwork/schres
Proofs
When your manuscript is received by the Publisher
it is considered to be in its final form. Proofs are not to be regarded as 'drafts'.
Authors should keep a copy of their manuscript
files as proofs will be sent to them without the original manuscript. One set of page proofs in PDF format will be sent by e-mail to
the corresponding author, to be checked for typesetting/editing. No changes in, or additions to, the accepted (and subsequently edited)
manuscript will be allowed at this stage. Proofreading is solely your responsibility. A form with queries from the copyeditor may accompany
your proofs. Please answer all queries and make any corrections or additions required. The Publisher reserves the right to proceed with
publication if corrections are not communicated. Return corrections within two days of receipt of the proofs. Should there be no corrections,
please confirm this. Elsevier will do everything possible to get your article corrected and published as quickly and accurately as possible.
In order to do this we need your help. When you receive the (PDF) proof of your article for correction, it is important to ensure that
all of your corrections are sent back to us in one communication. Subsequent corrections will not be possible, so please ensure your
first sending is complete. Note that this does not mean you have any less time to make your corrections, just that only one set of corrections
will be accepted.
Offprints
The corresponding author, at no cost, will be provided with a PDF file of the article via
e-mail. The PDF file is a watermarked version of the published article and includes a cover sheet with the Journal cover image and a
disclaimer outlining the terms and conditions of use. Additional paper offprints can be ordered by the authors. An order form with prices
will be sent to the corresponding Author. |
| |
|
